Amsterdam UMC

Leczenie i dostęp

• Oferowane terapieEsketamina w aerozolu do nosa (Spravato®)
• Ścieżka dostępuFinansowane z programu krajowego
• Koszt i finansowanie (status wg rejestru)Refundowane z holenderskiego podstawowego ubezpieczenia zdrowotnego (esketamina w aerozolu do nosa w TRD)
• RefundacjaCzłonek Esketamine Neusspray Consortium (ENC-NL); esketamina pokrywana wg protokołu ENC-NL Jak działa refundacja w Europie →
• Strona internetowahttps://www.amsterdamumc.org/nl/vandaag/neusspray-tegen-depressie

O tej placówce

Poniższe szczegóły profilu są po angielsku.

Amsterdam UMC is one of the Netherlands' university medical centers; its Psychiatry department (location AMC) began esketamine nasal spray treatment in early 2020, shortly after EMA approval. The spray is administered in the hospital under supervision of a medical professional, with about 90 minutes of observation per session because of short-lived side effects. Access runs exclusively via referral from a GP or the patient's current treating clinician; the treatment team cannot be approached directly. Amsterdam UMC also runs esketamine research and works with other Dutch centers on uniform outcome measurement.

Usługi i programy

Poniższe szczegóły profilu są po angielsku.

• Esketamine nasal spray for depression not responding to regular treatment: 2 sessions per week for 4 weeks in combination with an oral antidepressant; if effective, tapered to once a week or once every two weeks, often continuing as maintenance treatment
• In-hospital administration with roughly 90 minutes of observation per session; medication is collected from the hospital pharmacy by staff and never handed to the patient
• Esketamine study for patients who still have treatment options but had insufficient effect from 2 different antidepressants
• Regular depression care at the department includes medication, psychotherapy and electroconvulsive therapy (ECT)

Częste pytania

Poniższe szczegóły profilu są po angielsku.